MedPath

Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

Intraoperative Epiaortic Scanning for Preventing Early Stroke After Off-pump Coronary Artery Bypass

Completed
Conditions
Coronary Artery Occlusive Disease
First Posted Date
2013-01-10
Last Posted Date
2013-01-10
Lead Sponsor
Yonsei University
Target Recruit Count
2292
Registration Number
NCT01764763

Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study

Completed
Conditions
Non-Hodgkin's Lymphoma
First Posted Date
2013-01-08
Last Posted Date
2016-11-01
Lead Sponsor
Yonsei University
Target Recruit Count
500
Registration Number
NCT01763398
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

The Effect of Nafamostat Mesilate in Prolonging Filter Patency With Patients on Continuous Renal Replacement Therapy

Phase 4
Completed
Conditions
Acute Kidney Injury
Interventions
Drug: Anticoagulation with nafamostat mesilate
First Posted Date
2013-01-07
Last Posted Date
2013-01-07
Lead Sponsor
Yonsei University
Target Recruit Count
66
Registration Number
NCT01761994
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

The Change of the Detrusor Thickness After Hypospadias Repair - Comparison With the Normal Control Group

Withdrawn
Conditions
Hypospadias
First Posted Date
2013-01-07
Last Posted Date
2021-05-06
Lead Sponsor
Yonsei University
Registration Number
NCT01762007
Locations
🇰🇷

Sang Won, Seoul, Korea, Republic of

Time Serial Analysis on Preemptive Analgesia of Preoperative Topical Diclofenac and Ketorolac in Photorefractive Keratectomy(PRK)

Phase 3
Completed
Conditions
Myopes Who Have Undergone PRK.
Interventions
Drug: topical ketorolac 0.5% (Acular®, Allergan Inc, Irvine, CA)
Drug: topical diclofenac 0.1% (Voltaren®, Novartis, Bern, Switzerland)
First Posted Date
2013-01-04
Last Posted Date
2013-01-04
Lead Sponsor
Yonsei University
Target Recruit Count
94
Registration Number
NCT01761071
Locations
🇰🇷

Departement of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea, Republic of

Comparison Between Propofol-remifentanil Total Intravenous Anesthesia and Desflurane-remifentanil Balanced Anesthesia With Regard to Post-anesthetic Functional Recovery Measured With QoR-40

Not Applicable
Completed
Conditions
Thyroid Operation Under General Anesthesia
Interventions
Drug: TIVA group
Drug: desflurane group
First Posted Date
2013-01-03
Last Posted Date
2014-02-19
Lead Sponsor
Yonsei University
Target Recruit Count
76
Registration Number
NCT01760018
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Effect of Erythropoietin on the Incidence of Acute Kidney Injury Following Complex Valvular Heart Surgery

Phase 2
Completed
Conditions
Acute Kidney Injury
Interventions
Drug: Placebo
Drug: EPO group
First Posted Date
2013-01-01
Last Posted Date
2013-01-01
Lead Sponsor
Yonsei University
Target Recruit Count
98
Registration Number
NCT01758861
Locations
🇰🇷

Department of anesthesiology and pain medicine Yonsei University College of Medicine, Seoul, Korea, Republic of

The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease

Not Applicable
Completed
Conditions
Refractory Heart Failure
Chronic Kidney Disease
Interventions
Drug: Peritoneal dialysis (PD)
First Posted Date
2013-01-01
Last Posted Date
2019-03-29
Lead Sponsor
Yonsei University
Target Recruit Count
7
Registration Number
NCT01758627
Locations
🇰🇷

Division of Nephrology, Department of Internal Medicine Yonsei University College of Medicine, Seoul, Korea, Republic of

Clinical Significance of 64-slice Multidetector Coronary CT Angiography to Evaluate the Prevalence and Severity of Coronary Artery Disease in Renal Transplant Recipients

Not Applicable
Completed
Conditions
Kidney Transplant Recipient
Interventions
Other: 64-slice Multidetector coronary CT angiography
First Posted Date
2012-12-20
Last Posted Date
2017-11-28
Lead Sponsor
Yonsei University
Target Recruit Count
93
Registration Number
NCT01753505
Locations
🇰🇷

Severance hospital, Seoul, Korea, Republic of

DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)

Not Applicable
Completed
Conditions
Ischemic Heart Disease
Interventions
Device: PCI with BES under angio-guide or OCT guide
Device: PCI with EES under angio-guide or OCT guide
Drug: Discontinue DAPT
Drug: Keep DAPT
Device: OCT-guided PCI with EES or BES
Device: Angio-guided PCI with EES or BES
First Posted Date
2012-12-19
Last Posted Date
2019-03-21
Lead Sponsor
Yonsei University
Target Recruit Count
776
Registration Number
NCT01752894
Locations
🇰🇷

Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath